Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Comparing visual inspection with acetic acid, with and without Lugol's Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trialSelamawit Fisseha Mekuria, Habtamu Biazin, Tamrat Abebe, et al.
Gynecologic Oncology|April 11, 2024
Has time to chemotherapy from primary debulking surgery in advanced ovarian cancer an impact on survival? - A population-based nationwide SweGCG studyPernilla Dahm-Kähler, Angelique Flöter Rådestad, Erik Holmberg, et al.
Gynecologic Oncology|November 8, 2016
Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG)Pernilla Dahm-Kähler, Christer Borgfeldt, Erik Holmberg, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 28, 2022
Long-term incidence of endometrial cancer after endometrial resection and ablation: A population based Swedish gynecologic cancer group (SweGCG) studyAngelique Flöter Rådestad, Pernilla Dahm-Kähler, Erik Holmberg, et al.
Acta Oncologica (Stockholm, Sweden)|August 23, 2017
Data quality in the Swedish Quality Register of Gynecologic Cancer - a Swedish Gynecologic Cancer Group (SweGCG) studyPer Rosenberg, Preben Kjølhede, Christian Staf, et al.
Acta Oncologica (Stockholm, Sweden)|November 14, 2017
Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease - a Swedish Gynecologic Cancer Group (SweGCG) studyElisabet Hjerpe, Christian Staf, Pernilla Dahm-Kähler, et al.
Acta Oncologica (Stockholm, Sweden)|November 5, 2021
The wait time to primary surgery in endometrial cancer - impact on survival and predictive factors: a population-based SweGCG studyJanusz Marcickiewicz, Elisabeth Åvall-Lundqvist, Erik Carl Viktor Holmberg, et al.
Gynecologic Oncology|October 30, 2025
Primary treatment and survival in malignant ovarian germ cell tumors: A nationwide population-based Swedish Gynecologic Cancer Group (SweGCG) studyCamilla Sköld, Angelique Flöter Rådestad, Katja Stenström Bohlin, et al.
BMC Cancer|June 3, 2021
Survival in endometrial cancer in relation to minimally invasive surgery or open surgery - a Swedish Gynecologic Cancer Group (SweGCG) studyChrister Borgfeldt, Erik Holmberg, Janusz Marcickiewicz, et al.
Gynecologic Oncology|September 29, 2020
Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG studyKristina Hellman, Erik Holmberg, Maria Bjurberg, et al.
Pageof 10